Response of an ERBB2-mutated inflammatory breast carcinoma to human epidermal growth factor receptor 2-targeted therapy

Siraj M Ali, R Katherine Alpaugh, Sean R Downing, Philip J Stephens, Jian Q Yu, Hong Wu, Jamie K Buell, Vincent A Miller, Doron Lipson, Gary A Palmer, Jeffrey S Ross, Massimo Cristofanilli

Research output: Contribution to journalArticlepeer-review

43 Scopus citations
Original languageEnglish
Pages (from-to)e88-91
JournalJournal of Clinical Oncology
Volume32
Issue number25
DOIs
StatePublished - Aug 1 2014

Keywords

  • Antineoplastic Combined Chemotherapy Protocols/therapeutic use
  • Carcinoma, Ductal, Breast/drug therapy
  • Female
  • Humans
  • Inflammatory Breast Neoplasms/drug therapy
  • Lapatinib
  • Middle Aged
  • Molecular Targeted Therapy
  • Quinazolines/administration & dosage
  • Receptor, ErbB-2/genetics
  • Triple Negative Breast Neoplasms/drug therapy

Cite this